UP!

CTSO $7.88   View long term graphs

Cytosorbents Corporation
Traded as NASDAQ: CTSO
Industry Critical care
Headquarters Monmouth Junction, New Jersey, USA
Products CytoSorb
Number of employees
52

Cytosorbents Corporation is a publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, porous polymer beads that act like sponges in an attempt to remove harmful substances from the blood.

CytoSorb, the company's first product to market, received its CE mark approval in 2011.

CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins. The US Army awarded the Company a $1.15 million small-business innovation research contract to evaluate the technology in burn and trauma.


News

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-07-06 Reiterated Rating Maxim Group Buy $8.00
2016-06-15 Reiterated Rating Maxim Group Buy
2016-05-31 Reiterated Rating Maxim Group Buy
2016-05-24 Initiated Coverage Maxim Group Buy $8.00
2016-05-10 Reiterated Rating HC Wainwright Buy
2016-05-10 Reiterated Rating Brean Capital Buy
2016-03-10 Reiterated Rating Brean Capital Buy $25.00 to $24.00
2015-11-16 Reiterated Rating Brean Capital Buy $25.00
2015-10-29 Upgrade WBB Securities Speculative Buy to Buy $13.00
2015-08-17 Reiterated Rating Brean Capital Buy $25.00
2015-05-13 Reiterated Rating Brean Capital Buy $25.00
2015-05-12 Lower Price Target MLV & Co. Buy $28.00 to $21.00
2015-04-01 Boost Price Target MLV & Co. Buy $28.00 to $30.00
2015-03-05 Initiated Coverage MLV & Co. Buy $30.00
2015-02-25 Initiated Coverage WBB Securities Speculative Buy $13.00
2015-02-19 Set Price Target Brean Capital Buy $25.00
2015-01-27 Boost Price Target HC Wainwright Buy $1.00 to $12.00
2014-08-18 Initiated Coverage HC Wainwright Buy $1.00
2014-04-01 Boost Price Target Brean Capital Buy $0.50 to $1.00
2016-07-06 Reiterated Rating Maxim Group Buy $8.00
2016-06-15 Reiterated Rating Maxim Group Buy
2016-05-31 Reiterated Rating Maxim Group Buy
2016-05-24 Initiated Coverage Maxim Group Buy $8.00
2016-05-10 Reiterated Rating HC Wainwright Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments